← SynDRA
ATORVASTATIN
SynDRA canonical compound SYN0007875 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HMGCR |
| Mechanism of action | HMGCR inhibitor |
| Indication | heart attack | stroke |
| Disease area | cardiology | neurology/psychiatry |
All known targets
- HMGCR
- DPP4
- ABCG2
- AHR
- CYP3A4
- CYP3A5
- FASLG
- HDAC1
- HDAC2
- HDAC6
- NR1I3
Mechanisms of action (all sources)
- HMGCR INHIBITOR
- HMG-CoA reductase inhibitor
Drug classes
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- HMG-CoA Reductase Inhibitor
- Anticholesteremic Agents
- Antimetabolites
- Enzyme Inhibitors
- Hypolipidemic Agents
- Lipid Regulating Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
- LIPID MODIFYING AGENTS, COMBINATIONS
Cross-references
Synonyms
- CI-981
- CI981
- atorvastatin calcium hydrate
- atorvastatin calcium anhydrous
- atorvastatin acid
- cardyl
- atorvastatin calcium
- atorvastatin calcium trihydrate
- ATORVASTATINE
- ATORVASTATINA
- Atorvastatin calcium
- Cardyl
- Lipitor
- Prevencor
- Sortis
- Tahor
- Zarator
- Atogal
- Atorlip
- Atorpic
- Atorvastatina
- Atorvastatine
- Atorvastatinium
- Atrovastin
- Faboxim
- Lipotropic
- Lipovastatinklonal
- Liprimar
- Lowden
- Sincol
- Sotis
- Torvacard
- Torvast
- Totalip
- Tozalip
- Tulip
- Vastina
- Xanator
Reported adverse events
- Stevens-Johnson syndrome
- Rhabdomyolysis
- Arthralgia
- Insomnia
- Myalgia
- Myopathy
- Nasopharyngitis
- Nausea
- Dyspepsia
- Musculoskeletal pain
- Pain in extremity
- Urinary tract infection
Look up ATORVASTATIN in the interactive SynDRA portal →